Marie Linder

发表的论文12 篇，按出版时间

1. 1
   Lessons learned from a multi‐data source research collaboration: The mirabegron post‐authorization safety study programPharmacoepidemiology and Drug Safety20240
2. 2
   Consistency between the National Patient Register and the Swedish Cancer RegisterPharmacoepidemiology and Drug Safety20244
3. 3
   Patient characteristics and safety outcomes in new users of ticagrelor and clopidogrel—An observational cohort study in SwedenPharmacoepidemiology and Drug Safety20213
4. 4
   The use of uncertain exposure—A method to define switching and add‐on in pharmacoepidemiologyPharmacoepidemiology and Drug Safety20212
5. 5
   Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort StudyDrug Safety202125
6. 6
   Use of intravenous iron and risk of anaphylaxis: A multinational observational post‐authorisation safety study in EuropePharmacoepidemiology and Drug Safety20218
7. 7
   Influence of statin‐potency on the risk of kidney disease – A nationwide cohort study using laboratory dataPharmacoepidemiology and Drug Safety20202
8. 8
   Risk of common infections among individuals with psoriasis in Sweden: A nationwide cohort study comparing secukinumab to ustekinumabPharmacoepidemiology and Drug Safety202013
9. 9
   Classification and characteristics of on‐label and off‐label apixaban use in Denmark and SwedenPharmacoepidemiology and Drug Safety20198
10. 10
    Effectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and GermanyPharmacoepidemiology and Drug Safety20182